Peptide Antibiotics Market Analysis by Disease (Telavancin, Daptomycin), by Product Type (Non-ribosomal Synthesized Peptide Antibiotics), by Distribution Channel (Specialty Clinics, Hospitals), by Route of Administration (Topical, Oral), and by Region - Global Forecast to 2022-2033

The peptide antibiotics market size is estimated to be USD 6,210.8 million in 2022 and is expected to witness a CAGR of 6.45% during the forecast period 2023-2033. The increasing instances of antibiotic resistance, rising need for peptide antibiotics in hospitals and clinics, escalating number of product launches and approvals, and rise in incidence of illnesses such as bloodstream infections, hospital-acquired infections, and bacterial skin infections are factors contributing to the market growth. However, adverse effects of peptide antibiotics are expected to hinder the growth.

Segmentation

By Disease

Based on Disease, the market is segregated into blood stream infections, skin infections, HABP/VABP, and others. In 2022, the skin infections segment held the highest market share owing to increasing occurrence of bacterial skin illnesses such as carcuncles, impetigo, cellulitis, furuncles, and others, and widespread product availability.

By Product Type

On the basis of product type, the market is bifurcated into non-ribosomal synthesized peptide antibiotics and ribosomal synthesized peptide antibiotics. In 2022, the non-ribosomal synthesized peptide antibiotics segment held the highest market share due to the increasing accessibility of antibiotics made through a non-ribosomal synthesis, and rising demand for antibiotics made without ribosomes.

By Distribution Channel

Based on distribution channel, the market is segregated into specialty clinics, hospitals, homecare, and others. In 2022, the hospitals segment held the highest market share owing to increasing bacterial skin infections and ocular infections, and surging rates of hospital-acquired infections, bloodstream infections, and extended hospital stay.

By Route of Administration

Based on route of administration, the market is categorized into topical, oral, parenteral, and others. In 2022, the parenteral segment held the highest market share due to the availability of a large number of peptide antibiotics in injectable form, efficiency, and better bioavailability from injectable peptide antibiotics.

Regional Markets

In 2022, North America region accounted for the highest revenue in the peptide antibiotics market and is expected to maintain its dominance during the forecast period. This is attributed to the well-established pharmaceutical business, a strong emphasis on research and development (R&D), significant R&D investments, and the prominence of top pharmaceutical corporations.

Competitor Insights

Some of the key players operating in the peptide antibiotics market are Abbott (US), AbbVie Inc (US), Allergan Plc )Ireland), Dr. Reddy’s Laboratories Ltd (India), Fresenius Kabi AG (Germany), GSK (UK), HENGRUI (USA), Lilly (US), Merck (US), Novartis AG (Switzerland), Pfizer (US), Sandoz International GmbH (Germany), Sanofi (France), and Teva Pharmaceutical Industries Ltd. (Israel).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including disease, product type, distribution channel and route of administration from 2023 to 2033.

Report Scope:

Key Parameters Details
Market size in 2022
  • USD 6,210.8 Million
CAGR
  • 6.45%
Base Year
  • 2022
Forecast Period
  • 2023-2033
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • COVID-19 impact analysis
Segment Market Scope
  • Disease
  • Product Type
  • Distribution Channel
  • Route of Administration
Regional Market Scope
  • North America
    (U.S. and Canada)
  • Europe
    (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific
    (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America
    (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA
    (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • Other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Segmentation: Peptide Antibiotics Market Report 2022 – 2033

Disease (Revenue, USD Million), 2022 – 2033

  • Blood Stream Infections
  • Skin Infections
  • HABP/VABP
  • Others

Product Type (Revenue, USD Million), 2022 – 2033

  • Non-ribosomal Synthesized Peptide Antibiotics
  • Ribosomal Synthesized Peptide Antibiotics

Distribution Channel (Revenue, USD Million), 2022 – 2033

  • Specialty Clinics
  • Hospitals
  • Homecare
  • Others

By Route of Administration (Revenue, USD Million), 2022 – 2033

  • Topical
  • Oral
  • Parenteral
  • Others

By Region (Revenue, USD Million), 2022 – 2033

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents: Peptide Antibiotics Market 2022-2033

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
  1. Introduction: Peptide Antibiotics
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. SWOT Analysis
  2. COVID-19 Impact Analysis: Peptide Antibiotics Market 
  3. Market Analysis by Disease
    1. Blood Stream Infections
      1. Blood Stream Infections Market Forecast, 2022-2033 (USD Million)
    2. Skin Infections
      1. Skin Infections Market Forecast, 2022-2033 (USD Million)
    3. HABP/VABP
      1. HABP/VABP Market Forecast, 2022-2033 (USD Million)
    4. Others
      1. Others Market Forecast, 2022-2033 (USD Million)
  1. Market Analysis by Product Type
    1. Non-ribosomal Synthesized Peptide Antibiotics
      1. Non-ribosomal Synthesized Peptide Antibiotics Market Forecast, 2022-2033 (USD Million)
    2. Ribosomal Synthesized Peptide Antibiotics
      1. Ribosomal Synthesized Peptide Antibiotics Market Forecast, 2022-2033 (USD Million)
  1. Market Analysis by Distribution Channel
    1. Specialty Clinics
      1. Specialty Clinics Market Forecast, 2022-2033 (USD Million)
    2. Hospitals
      1. Hospitals Market Forecast, 2022-2033 (USD Million)
    3. Homecare
      1. Homecare Market Forecast, 2022-2033 (USD Million)
    4. Others
      1. Others Market Forecast, 2022-2033 (USD Million)
  1. Market Analysis by Route of Administration
    1. Topical
      1. Topical Market Forecast, 2022-2033 (USD Million)
    2. Oral
      1. Oral Market Forecast, 2022-2033 (USD Million)
    3. Parenteral
      1. Parenteral Market Forecast, 2022-2033 (USD Million)
    4. Others
      1. Others Market Forecast, 2022-2033 (USD Million)
      2. & Government Institutes Market Forecast, 2022-2033(USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
  2. North AmericaPeptide Antibiotics Market  
    1. North AmericaPeptide Antibiotics Market
      1. North America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease, 2022-2033(USD Million)
        2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
      2. S.Peptide Antibiotics Market
        1. S. Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Disease, 2022-2033(USD Million)
          2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
        2. CanadaPeptide Antibiotics Market
          1. Canada Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease, 2022-2033(USD Million)
            2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
            4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
  1. EuropePeptide Antibiotics Market  
    1. EuropePeptide Antibiotics Market
      1. Europe Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease, 2022-2033(USD Million)
        2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
      2. GermanyPeptide Antibiotics Market
        1. Germany Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Disease, 2022-2033(USD Million)
          2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
        2. UKPeptide Antibiotics Market
          1. UK Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease, 2022-2033(USD Million)
            2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
            4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
          2. FrancePeptide Antibiotics Market
            1. France Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Disease, 2022-2033(USD Million)
              2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
              3. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
              4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
            2. SpainPeptide Antibiotics Market
              1. Spain Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Disease, 2022-2033(USD Million)
                2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
                3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
                4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
              2. ItalyPeptide Antibiotics Market
                1. Italy Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Disease, 2022-2033(USD Million)
                  2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
                  3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
                  4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
                2. Rest of EuropePeptide Antibiotics Market
                  1. Rest of Europe Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Disease, 2022-2033(USD Million)
                    2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
                    3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
                    4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
  1. Asia PacificPeptide Antibiotics Market  
    1. Asia PacificPeptide Antibiotics Market
      1. Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease, 2022-2033(USD Million)
        2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
      2. JapanPeptide Antibiotics Market
        1. Japan Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Disease, 2022-2033(USD Million)
          2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
        2. ChinaPeptide Antibiotics Market
          1. China Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease, 2022-2033(USD Million)
            2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
            4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
          2. IndiaPeptide Antibiotics Market
            1. India Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Disease, 2022-2033(USD Million)
              2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
              4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
            2. South KoreaPeptide Antibiotics Market
              1. South Korea Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Disease, 2022-2033(USD Million)
                2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
                3. Market Size and Forecast by Distribution Channel,2022-2033 (USD Million)
                4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
              2. AustraliaPeptide Antibiotics Market
                1. Australia Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Disease, 2022-2033(USD Million)
                  2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
                  3. Market Size and Forecast by Distribution Channel 2022-2033(USD Million)
                  4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
                2. Rest of Asia PacificPeptide Antibiotics Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Disease, 2022-2033(USD Million)
                    2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
                    3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
                    4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
  1. Latin America Peptide Antibiotics Market  
    1. Latin AmericaPeptide Antibiotics Market
      1. Latin America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease, 2022-2033(USD Million)
        2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
      2. BrazilPeptide Antibiotics Market
        1. Brazil Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
        2. MexicoPeptide Antibiotics Market
          1. Mexico Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease, 2022-2033(USD Million)
            2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
            4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
          2. ArgentinaPeptide Antibiotics Market
            1. Argentina Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Disease, 2022-2033(USD Million)
              2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
              4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
            2. Rest of Latin AmericaPeptide Antibiotics Market
              1. Rest of Latin America Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Disease, 2022-2033(USD Million)
                2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
                3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
                4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
  1. MEAPeptide Antibiotics Market  
    1. MEAPeptide Antibiotics Market
      1. MEA Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease, 2022-2033(USD Million)
        2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
        3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
        4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
      2. GCCPeptide Antibiotics Market
        1. GCC Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Disease, 2022-2033(USD Million)
          2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
          3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
          4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
        2. South AfricaPeptide Antibiotics Market
          1. South Africa Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease, 2022-2033(USD Million)
            2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
            3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
            4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
          2. Rest of MEAPeptide Antibiotics Market
            1. Rest of MEA Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Disease, 2022-2033(USD Million)
              2. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
              3. Market Size and Forecast by Distribution Channel, 2022-2033(USD Million)
              4. Market Size and Forecast byEnd user, 2022-2033 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2022
    2. Major Recent Developments, 2019-2022
  2. Company Profiles
    1. Abbott (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. AbbVie Inc (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. Allergan Plc )Ireland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. Reddy’s Laboratories Ltd (India)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. Fresenius Kabi AG (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. GSK (UK)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. HENGRUI (USA)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. Lilly (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. Merck (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. Novartis AG (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. Pfizer (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Sandoz International GmbH (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Sanofi (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. Teva Pharmaceutical Industries Ltd. (Israel)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
  1. Conclusion & Recommendations

Leave a comment

Your email address will not be published. Required fields are marked *

Select License Type

5 reasons to choose Quintana Research Reports

Our top-quality, real-time, accurate, and data-driven research aims at empowering the clients with actionable insights.

We deliver timely data-driven insights to help clients make informed decisions and achieve growth and success.

Our team of experts is available 24*7 to offer incisive analysis of the market for clients.

We offer comprehensive and bespoke marketing research as per clients’ requirements.

Our cost-effective and rapid research helps clients gain competitive intelligence, and uncover potential opportunities & threats.